“In the beginning, all clinical studies and clinical applications take place only in the adult population, and only then the transition to the pediatric population occurs.
Such a study is planned, will be carried out during this year, "- quoted by TASS.
At the end of November 2020, Rinat Maksyutov, Director General of the State Scientific Center for Virology and Biotechnology "Vector" of Rospotrebnadzor, spoke about plans for clinical trials of the COVID-19 vaccine in children.